Dublin, Dec. 19, 2018 (GLOBE NEWSWIRE) — The “Infectious Disease Diagnostics Conference” conference has been added to ResearchAndMarkets.com’s offering.
According to the World Health Organization, 17 million deaths are caused each year by infectious diseases, accounting for nearly 30% of the annual mortality rate worldwide.
Lower respiratory tract infections, HIV/AIDS, gastro- intestinal diseases, malaria and tuberculosis are together responsible for nearly one-third of all deaths. Various technological developments and advancements in in vitro diagnostics have led to a new variety of diagnostic tests, allowing patients to access novel treatments earlier.
This conference aims to bring different stakeholders together from hospitals, laboratories academic institutes and IVD industry leaders to discuss about the emerging technologies and potential growth of molecular diagnostics and challenges faced in point-of-care testing and antimicrobial resistance. Keynote presentations, Brainstorming Panel Discussions and Case studies will give the stakeholders an opportunity to discuss and understand the issues faced.
Key Highlights:
- Discussion on the treatment and diagnosis of fungal infection, flu, Hepatitis C
- Antibiotic Resistance: Consequences of overtreating infectious disease
- Talks on Neglected Tropical Diseases (NTDs) diagnostic
- Rapid TB/Ref R testing
- The clinical need for better antimicrobial resistance related diagnostics
- Treatments of MDR gram negative bacteria
- Time required to diagnosis vancomycin-resistant enterococci (VRE)
Agenda:
Day 1
08:00 Registration
08:55 Welcome note
09:05 Opening remarks from the Chairman
Challenges in diagnosis and treatment
09:10 Invasive aspergillosis: emerging azole resistance and new diagnostic technologies
– Invasive aspergillosis
– Azole resistance
– Diagnostic tools
Dr.Willem Melchers, Associate Professor, Radboud University, The Netherlands
09:40 Invasive aspergillosis in intensive care
10:10 Is C-Reactive Protein point of care testing feasible in routine general practice improving diagnostic certainty and antibiotic use?
– AMR is a threat to future health care and one of the main causes being an inappropriate prescribing of antibiotics
– NICE pathway CG 191 published in Dec 2014 recommends that GPs should do PoC CRP test for people presenting in primary care with symptoms suggestive of lower respiratory tract infection
– The biggest issue is funding and what to do
Dr Anita Sharma, GP and Clinical Director Vascular Oldham CCG, NICE QSAC GP Member
South Chadderton Health Centre
10:40 Morning Refreshment and Poster Presentation – One to One Meetings
11:30 Diagnostic challenges for the WHO Hepatitis C elimination targets
– What are the WHO elimination targets?
– What are the obstacles to achieving those targets?
– How can innovative approaches to diagnosis and treatment overcome those obstacles?
Prof. William Irving, Professor of Virology, Nottingham University, UK
12:00 Virological diagnostic dilemmas:
– Molecular investigation of a series of bone marrow transplant recipients with acute hepatitis B virus infection
– Acute on chronic hepatological confusion – diagnostic conundrum
– Molecular investigation of a possible outbreak of rhinovirus infection in a bone marrow transplant unit
Dr. Mark Zuckerman, Consultant Virologist and Head of Virology, King’s College Hospital NHS Trust, UK
12:30 Presentation by Diasorin Ltd UK
13:00 Lunch and Poster Presentation – One to One Meetings
14:00 Investing in effective diagnostics for parasitic and tropical diseases
14:30 Updates on the diagnosis of sexually transmitted infections
Molecular diagnostics development
15:00 Emerging enteroviruses: Enterovirus D68 as the new polio?
– Diagnostic stewardship for enterovirus
– Acute flaccid myelitis (AFM) and enterovirus D68
– Where diagnostics ends and epidemiology starts
Prof. Dr. H.G.M. Niesters, Medical Microbiology and Director, Laboratory of Clinical Virology, University Medical Centre
Groningen, The Netherlands
15:30 Afternoon Refreshment and Poster Presentation – One to One Meetings
16:20 Evaluating diagnostics for patients with influenza and other respiratory viruses
– New rapid testing possibilities
– POCT or syndromic testing
– Threat of emerging influenza subtypes
Dr Eric C.J Claas, Molecular Medical Microbiologist, Department of Medical Microbiology, Leiden University Medical Centre, The Netherlands
17:20 Diagnosis of non-polio enterovirus infections
– Importance of old and emerging non-polio enterovirus types in Europe
– Diagnostic challenges we currently face with non-polio enteroviruses
– Future needs in the field of non-polio enteroviruses
Dr Heli Harvala, Consultant Medical Virologist, NHS Blood and Transplant, UK
17:20 Chairman’s closing remarks
17:30 Drinks Reception
Day 2
08:00 Registration
08:55 Welcome note
09:05 Opening remarks from the Chairman
09:10 New technologies in Microbiology and their potential impact on clinical practice
Dr Manjusha Narayanan, Consultant Microbiologist, Royal Victoria Infirmary and Freeman Hospital, Newcastle upon
Tyne Hospitals NHS Foundation Trust
09:40 Point of care diagnostics and the Medtech IVD collaborative
Prof. Graham Cooke, NIHR Professor of Infectious Diseases, Imperial College London, UK
10:10 Reduction in time required to diagnosis vancomycin-resistant enterococci (VRE)
10:40 Morning Refreshment and Poster Presentation – One to One Meetings
11:30 Investing in effective diagnostics for parasitic diseases
– What are we looking for (what to expect in a non-endemic setting
– Validation and implementation
– Quality assessment
Dr. Jaco Verweij, Medical Molecular Microbiologist, St. Elisabeth Ziekenhuis, LMMI
12:00 Antibiotic Resistance: consequences of over-treating infectious diseases
12:30 Influenza-associated aspergillosis (IAA)
– Influenza is a newly recognized risk group for invasive pulmonary aspergillosis
– IAA may develop in previously healthy individuals
– The clinical presentation of IAA is atypical
– IAA carries a mortality of 45% and requires immediate treatment
Paul Verweij, Professor of Clinical Mycology, Elisabeth Tweesteden Hospital, The Netherlands
13:00 Lunch and Poster Presentation – One to One Meetings
14:00 Breakout Sessions:
Track A- Early diagnostics methods to fight antimicrobial resistance
Track B- Side effects of over prescription of antibiotics
Track C- Investigations in Tropical Diseases
15:15 Closing remarks form the Chairman – End of Conference
For more information about this conference visit https://www.researchandmarkets.com/research/vtpzk9/infectious?w=12
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
CONTACT:
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Infectious Disease Testing
